Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Galvin, John P. [1 ]
Monreal, Joanne [1 ]
Mehta, Jayesh [1 ]
机构：
[1] NW Mem Hosp, Chicago, IL 60611 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2012.11.417
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
361
引用
收藏
页码：S290 / S290
页数：1
相关论文
共 50 条
  • [1] ASSESSMENT OF THE HEMATOPOIETIC CELL TRANSPLANTATION COMORBIDITY INDEX IN OLDER PATIENTS RECEIVING REDUCED-INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Galvin, J. Patrick
    Mehta, J.
    Monreal, J.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S201 - S202
  • [2] Assessment Of The Hematopoietic Cell Transplantation Comorbidity Index In Older Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
    Keebler, Chandra
    Monreal, Joanne
    Altman, Jessica K.
    Frankfurt, Olga
    Gordon, Leo I.
    Galvin, John
    Mehta, Jayesh
    BLOOD, 2013, 122 (21)
  • [3] Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Non-Hodgkin Lymphoma Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
    Pollack, Seth M.
    Steinberg, Seth M.
    Odom, Jeanne
    Dean, Robert M.
    Fowler, Daniel H.
    Bishop, Michael R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 223 - 230
  • [4] Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced intensity allogeneic hematopoietic cell transplantation
    Pollack, S.
    Steinberg, S.
    Odom, J.
    Dean, R.
    Fowler, D.
    Bishop, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Limitations of Applying the Hematopoietic Cell Transplantation Comorbidity Index in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation
    Broglie, Larisa
    Ruiz, Jenny
    Jin, Zhezhen
    Kahn, Justine M.
    Bhatia, Monica
    George, Diane
    Garvin, James
    Satwani, Prakash
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (01):
  • [6] Validation of Comorbidity Indexes in Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation. the Hematopoietic Cell Transplantation Comorbidity Index Is the Best Predictor of NRM and Survival
    Barba, Pere
    Pinana, Jose Luis
    Amoros, Alex
    Valcarcel, David
    Martino, Rodrigo
    Sureda, Anna
    Briones, Javier
    Delgado, Julio
    Granell, Miquel
    Brunet, Salut
    Sunol, Ma Rosa
    Sierra, J.
    BLOOD, 2008, 112 (11) : 1125 - 1125
  • [7] Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis
    Haefaa Alchalby
    Nicolaus Kröger
    Current Hematologic Malignancy Reports, 2010, 5 : 53 - 61
  • [8] Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis
    Alchalby, Haefaa
    Kroeger, Nicolaus
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (02) : 53 - 61
  • [9] Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma
    Efebera, Yvonne A.
    Qureshi, Sofia R.
    Cole, Suzanne M.
    Saliba, Rima
    Pelosini, Matteo
    Patel, Ronak M.
    Koca, Ebru
    Mendoza, Floralyn L.
    Wang, Michael
    Shah, Jatin
    Alousi, Amin
    Hosing, Chitra
    Popat, Uday
    Kebriaei, Partow
    Anderlini, Paolo
    Khouri, Issa F.
    Champlin, Richard
    Giralt, Sergio
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (08) : 1122 - 1129
  • [10] Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation
    Nihtinen, A
    Volin, L
    Juvonen, E
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 2003, 31 : S159 - S159
12345